EUVIMEDEUVIMED entdecken
Crossref

Building a B Cell Differentiation Model for X-Linked Agammaglobulinemia Using Pluripotent Stem Cells

Elaine M. Hernández González, Matthew Hebden Porteus, Hana Y. Ghanim, Scott J. Dixon, Stanford University, Department of Biology

Stanford Digital Repository · 05.05.2023

DOI: 10.25740/nf436hf9370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 05.05.2023. Verfasst von Elaine M. Hernández González und 5 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-Linked Agammaglobulinemia (XLA) is the most common primary immunodeficiency in males in the United States. It is characterized by the inability to produce mature B cells due to mutations in the BTK gene. Current treatments involve repeated injection of immunoglobulins, but these have limitations, as patients can have adverse reactions and this treatment does not replace the entire immune response. As a result, gene correction is considered a viable therapy for XLA; however, a robust B cell differentiation model to study the effect of using gene therapy to treat XLA has not been established. Although cytokines are not sufficient to induce differentiation, studies have shown that transcription factor-driven differentiation systems have been proven to be successful in producing differentiated cells from pluripotent stem cells (PSCs). Therefore, this project aimed to study and replicate B cell development in vitro with the purpose of designing a new differentiation model using B cell-specific transcription factors (TFs), EBF1 and PAX5. This was approached by using the gene editing tool clustered regularly interspaced short palindromic repeats-Cas9 (CRISPR-Cas9) and adeno-associated virus type 6 (AAV6) on human PSCs. First, assessment of wild type PSC potential to differentiate into B cells using cytokines confirmed inefficient B cell development. Then, an in-depth study of BTK mutations led to the generation of three pluripotent XLA-knockout cell lines that imitate the disease phenotype. The design and integration of GFP reporter constructs into the B-cell specific marker CD20 is still being studied. Finally, TF constructs were designed with the purpose of enhancing a cytokine-based B cell differentiation. These results support the development of PSC lines with transgenic B cell differentiation TFs as a model for XLA and other B cell-related malignancies, while eliminating the need for patients to provide bone marrow or hematopoietic stem cell samples.

Schlagwörter

X-linked agammaglobulinemiaB cell differentiationpluripotent stem cellsBTK mutationsEBF1PAX5transcription factorsCRISPR/Cas9 genome editingprimary immunodeficiencyin vitro differentiation model

Zitieren

APA

González, E. M. H., Porteus, M. H., Ghanim, H. Y., Dixon, S. J., University, S., & Biology, D. O. (2023). Building a B Cell Differentiation Model for X-Linked Agammaglobulinemia Using Pluripotent Stem Cells. Stanford Digital Repository. https://doi.org/10.25740/nf436hf9370

Vancouver

González EMH, Porteus MH, Ghanim HY, Dixon SJ, University S, Biology DO. Building a B Cell Differentiation Model for X-Linked Agammaglobulinemia Using Pluripotent Stem Cells. Stanford Digital Repository. 2023. doi:10.25740/nf436hf9370

BibTeX
@article{Gonzlez2023,
  author = {González, Elaine M. Hernández and Porteus, Matthew Hebden and Ghanim, Hana Y. and Dixon, Scott J. and University, Stanford and Biology, Department of},
  title = {Building a B Cell Differentiation Model for X-Linked Agammaglobulinemia Using Pluripotent Stem Cells},
  journal = {Stanford Digital Repository},
  year = {2023},
  doi = {10.25740/nf436hf9370}
}
Kostenlos starten →